dianhydrogalactitol has been researched along with tamoxifen in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Görlich, M; Heise, E; Kerpel-Fronius, S; Számel, I | 1 |
| Grönroos, M; Kangas, L; Mäenpää, J; Paul, R; Vanharanta, R | 1 |
2 other study(ies) available for dianhydrogalactitol and tamoxifen
| Article | Year |
|---|---|
Chemotherapeutic agents and estradiol receptor binding capacity.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Carcinoma; Dianhydrogalactitol; Estradiol; Female; Fluorouracil; Humans; In Vitro Techniques; Lymphatic Metastasis; Mammary Neoplasms, Experimental; Mechlorethamine; Nafoxidine; Rats; Receptors, Estrogen; Tamoxifen; Uterus | 1979 |
Steroid receptors and response of ovarian cancer to cytostatic drugs in vitro.
Topics: Adult; Aged; Alkylating Agents; Antineoplastic Combined Chemotherapy Protocols; Cell Survival; Cells, Cultured; Cisplatin; Cystadenocarcinoma; Dianhydrogalactitol; Doxorubicin; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Ovarian Neoplasms; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen | 1984 |